Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumor × mirdametinib × 1 year × Clear all

Sponsor

Conditions

Neurofibromatoses 2 Vascular Malformations 1 Skin Diseases, Vascular 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurofibroma 1 NF1 1 Multiple Myeloma 1 Melanoma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Arteriovenous Malformations 1

Interventions

Injections 11 tislelizumab 9 pembrolizumab 7 toripalimab 5 atezolizumab 4 Paclitaxel 4 Carboplatin 4 Bevacizumab 4 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 olaparib 2 niraparib 2 lenvatinib 2 Pemetrexed 2 Leucovorin 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 zimberelimab 1 trastuzumab deruxtecan 1 talazoparib 1 spartalizumab 1 sintilimab 1 serabelisib 1 penpulimab 1 nedaplatin 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡